Modular Solutions
The Biomarkers & Assays database launched with Lung Cancer as its first modality, with several additional products currently being explored.
Our Current Solutions
Lung Cancer
Covering all biomarkers, assays and clinical trials investigating targeted therapies within the lung cancer landscape.
What our customers say
“[Biomarkers & Assays] is going to be a blockbuster in my opinion. It’s very valuable. There's no doubt about it… If I can delve into this information sooner rather than later before we write protocols and such, it's going to be amazing.”
Senior Vice President – Translational Sciences
Multinational Biopharmaceutical Company